Caladrius Biosciences, Inc. (CLBS) News Headlines

▮ More

Date

Headline

3/8/2021 8:12:08 AM Caladrius Biosciences Reports Orphan Drug Designation For CLBS12 For Treatment Of Buerger’s Disease

1/21/2021 5:46:40 AM Pre-market Movers In Healthcare Sector: ADXN, CLSN, CLBS, JAGX, ECOR, ADMP…

1/21/2021 12:48:03 AM PFE/BNTX Covid Jab Neutralizes UK Strain, Pura Vida Ups Stake In OCX, Woodcock Is Interim FDA Chief

1/20/2021 10:16:38 AM Stock Alert: Caladrius Biosciences Hits New High

11/2/2020 8:38:19 AM Caladrius Biosciences Appoints Anne Whitaker To Board

7/16/2020 12:55:37 AM GRTX Awaits Pancreatic Cancer Trial Data, GENE Jumps, MNK Gets FDA Panel Backing, TCDA Disappointed

7/15/2020 2:58:10 AM AZN, IQV Team Up To Accelerate COVID-19 Vaccine Work, RIGL's ITP Drug Repurposed, IMV On Watch

6/2/2020 8:10:45 AM Caladrius To Present On CLBS119 For COVID-19 Induced Lung Damage At BioNJ COVID-19 Rapid Fire Research Showcase

5/26/2020 8:05:11 AM Caladrius Biosciences Announces $4.3 Mln Direct Offering

4/22/2020 8:06:00 AM Caladrius To Get $10.9 Mln Of Non-Dilutive Capital Through NJEDA' Technology Business Tax Certificate Transfer Program

5/14/2019 6:43:19 AM WBB Securities Starts Caladrius Biosciences, Inc. (CLBS) At Speculative Buy With $6.75 Price Target

Older Articles